Engineering probiotics as living biotherapeutics: a novel paradigm of restoring physiological barriers via targeted short-chain fatty acid delivery
Crossref DOI link: https://doi.org/10.1007/s11427-025-3185-y
Published Online: 2025-12-23
Published Print: 2026-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kang, Guangbo
Zhang, Biao
Wu, Jiahao
Wang, Lina
Huang, He
Text and Data Mining valid from 2025-12-23
Version of Record valid from 2025-12-23
Article History
Received: 7 October 2025
Accepted: 8 December 2025
First Online: 23 December 2025
Compliance and ethics
: The authors declare that they have no conflict of interest.